Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2020 - Page 2

Year: 2020

Resverlogix announced apabetalone treatment prior to SARS-CoV-2 exposure reduced viral infection
COVID-19 | Life Science History

Resverlogix announced apabetalone treatment prior to SARS-CoV-2 exposure reduced viral infection

On Dec. 22, 2020, Resverlogix announced published findings in the Proceedings of the National Academy of Sciences (PNAS),…

Read More Resverlogix announced apabetalone treatment prior to SARS-CoV-2 exposure reduced viral infectionContinue

NIH neuroscientists isolated promising mini antibodies against COVID-19 from a llama
Life Science History | Nanotechnology | NIH

NIH neuroscientists isolated promising mini antibodies against COVID-19 from a llama

On Dec. 22, 2020, the NIH researchers announced they had isolated a set of promising, tiny antibodies, or…

Read More NIH neuroscientists isolated promising mini antibodies against COVID-19 from a llamaContinue

NIH ACTIV Trial of blood thinners paused enrollment of critically ill COVID-19 patients
COVID-19 | Life Science History | NIH

NIH ACTIV Trial of blood thinners paused enrollment of critically ill COVID-19 patients

On Dec. 22, 2020, the NIH researchers announced that three clinical trial platforms working together to test the…

Read More NIH ACTIV Trial of blood thinners paused enrollment of critically ill COVID-19 patientsContinue

Sorrento announced it had submitted an EUA application to the FDA for COVI-STIX rapid test for detection of SARS-CoV-2 antigen
Biotechnology | COVID-19 | FDA | Therapeutics

Sorrento announced it had submitted an EUA application to the FDA for COVI-STIX rapid test for detection of SARS-CoV-2 antigen

On Dec. 22, 2020, Sorrento Therapeutics announced that an Emergency Use Authorization (EUA) Application had been submitted to…

Read More Sorrento announced it had submitted an EUA application to the FDA for COVI-STIX rapid test for detection of SARS-CoV-2 antigenContinue

Abivax’s Covid-19 phase 2b/3 miR-AGE trial with ABX464 declared National Priority by French government
Life Science History

Abivax’s Covid-19 phase 2b/3 miR-AGE trial with ABX464 declared National Priority by French government

On Dec. 22, 2020, Abivax announced that the Companyメs ongoing ABX464 phase 2b/3 trial in high-risk Covid-19 patients…

Read More Abivax’s Covid-19 phase 2b/3 miR-AGE trial with ABX464 declared National Priority by French governmentContinue

COVID-19 targeted treatment trial launched in Vienna
COVID-19 | Life Science History

COVID-19 targeted treatment trial launched in Vienna

On Dec. 22, 2020, a phase II clinical trial of a treatment for COVID-19 patients was started at…

Read More COVID-19 targeted treatment trial launched in ViennaContinue

RedHill’s phase 2/3 COVID-19 study of opaganib passed second DSMB with unanimous recommendation
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

RedHill’s phase 2/3 COVID-19 study of opaganib passed second DSMB with unanimous recommendation

On Dec. 22, 2020, RedHill Biopharma announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva, ABC294640)1…

Read More RedHill’s phase 2/3 COVID-19 study of opaganib passed second DSMB with unanimous recommendationContinue

CDC’s ACIP updated interim recommendation for allocation of COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

CDC’s ACIP updated interim recommendation for allocation of COVID-19 vaccine

On Dec. 22, 2020, the ACIP updated interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be…

Read More CDC’s ACIP updated interim recommendation for allocation of COVID-19 vaccineContinue

Cocrystal Pharma selected lead compound for further development against Coronaviruses
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

Cocrystal Pharma selected lead compound for further development against Coronaviruses

On Dec. 22, 2020, Cocrystal Pharma announced the selection of CDI-45205 as the lead compound for further development…

Read More Cocrystal Pharma selected lead compound for further development against CoronavirusesContinue

Singapore approved sale of lab-grown meat in world first
Life Science History

Singapore approved sale of lab-grown meat in world first

On Dec. 1, 2020, the governmenrt of Singapore announced that it had given U.S. start-up Eat Just the…

Read More Singapore approved sale of lab-grown meat in world firstContinue

CureVac and University Medical Center Mainz started phase 3 clinical trial for COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

CureVac and University Medical Center Mainz started phase 3 clinical trial for COVID-19 vaccine candidate

On Dec. 21, 2020, CureVac announced that the first participant in a clinical Phase 3 study with its…

Read More CureVac and University Medical Center Mainz started phase 3 clinical trial for COVID-19 vaccine candidateContinue

CVS Health began administering COVID-19 vaccines in long-term care facilities
COVID-19 | Life Science History | Vaccine

CVS Health began administering COVID-19 vaccines in long-term care facilities

On Dec. 21, 2020, CVS Health announced it had formally launched its COVID-19 vaccination program for long-term care…

Read More CVS Health began administering COVID-19 vaccines in long-term care facilitiesContinue

NIH announced support of radical approaches to nationwide COVID-19 testing and surveillance
COVID-19 | Life Science History | NIH

NIH announced support of radical approaches to nationwide COVID-19 testing and surveillance

On Dec. 21, 2020, the NIH announced that it had awarded over $107 million to support new, non-traditional…

Read More NIH announced support of radical approaches to nationwide COVID-19 testing and surveillanceContinue

NIH funded eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in children
COVID-19 | Environmental | Life Science History | NIH

NIH funded eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in children

On Dec. 21, 2020, the NIH announced that it had awarded eight research grants to develop approaches for…

Read More NIH funded eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in childrenContinue

Reston Ebolavirus spreads efficiently in pigs
Biotechnology | Environmental | Infectious Disease | NIH

Reston Ebolavirus spreads efficiently in pigs

On Dec. 21, 2020, the U.S. National Institutes of Health (NIH) announced a study published in the Proceedings…

Read More Reston Ebolavirus spreads efficiently in pigsContinue

New SARS-CoV-2 variant identified through viral genomic sequencing in United Kingdom and Northern Ireland
Biotechnology | COVID-19 | Diagnostics | Genomics | Vaccine | WHO

New SARS-CoV-2 variant identified through viral genomic sequencing in United Kingdom and Northern Ireland

On Dec. 21, 2020, the WHO reported that authorities of the United Kingdom of Great Britain and Northern…

Read More New SARS-CoV-2 variant identified through viral genomic sequencing in United Kingdom and Northern IrelandContinue

U.S. Dept. of Veterans Affairs began COVID-19 vaccinations at 128 additional sites
Biotechnology | COVID-19 | Infectious Disease | Vaccine

U.S. Dept. of Veterans Affairs began COVID-19 vaccinations at 128 additional sites

On Dec. 21, 2020, the U.S. Dept. of Veterans Affairs (VA) announced that it had begun COVID-19 vaccinations…

Read More U.S. Dept. of Veterans Affairs began COVID-19 vaccinations at 128 additional sitesContinue

European Commission approved Aimmune’s PALFORZIA as first-ever treatment for peanut allergy in the EU
Agriculture | Biotechnology | Diagnostics | Disease | Therapeutics

European Commission approved Aimmune’s PALFORZIA as first-ever treatment for peanut allergy in the EU

On Dec. 21, 2020, Aimmune Therapeutics announced that the European Commission (EC) had approved PALFORZIA [defatted powder of…

Read More European Commission approved Aimmune’s PALFORZIA as first-ever treatment for peanut allergy in the EUContinue

Quidel received Emergency Use Authorization for QuickVue SARS rapid antigen test for COVID-19 diagnosis
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza

Quidel received Emergency Use Authorization for QuickVue SARS rapid antigen test for COVID-19 diagnosis

On Dec. 21, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…

Read More Quidel received Emergency Use Authorization for QuickVue SARS rapid antigen test for COVID-19 diagnosisContinue

FDA granted IND approval for phase 2 clinical trial of Innovation Pharmasメ Brilacidin for treating COVID-19
COVID-19 | FDA | Life Science History

FDA granted IND approval for phase 2 clinical trial of Innovation Pharmasメ Brilacidin for treating COVID-19

On Dec. 21, 2020, Innovation Pharma announced that the FDA had approved the Companyメs Investigational New Drug (IND)…

Read More FDA granted IND approval for phase 2 clinical trial of Innovation Pharmasメ Brilacidin for treating COVID-19Continue

First patients, including a COVID-19 patient, treated with Abiomed’s ECMO technology
Medical Device

First patients, including a COVID-19 patient, treated with Abiomed’s ECMO technology

On Dec. 21, 2020, Abiomed announced the first two patients in the world had been treated with the…

Read More First patients, including a COVID-19 patient, treated with Abiomed’s ECMO technologyContinue

FDA granted IND approval for phase 2 clinical trial of Innovation Pharma’s Brilacidin for treating COVID-19
COVID-19 | FDA | Life Science History

FDA granted IND approval for phase 2 clinical trial of Innovation Pharma’s Brilacidin for treating COVID-19

On Dec. 21, 2020, Innovation Pharmaceuticals announced that the FDA had approved the Companyメs Investigational New Drug (IND)…

Read More FDA granted IND approval for phase 2 clinical trial of Innovation Pharma’s Brilacidin for treating COVID-19Continue

Labcorp made Pixel At-Home COVID-19 Collection Kit available through Walgreens Find Careᆴ
COVID-19 | Life Science History

Labcorp made Pixel At-Home COVID-19 Collection Kit available through Walgreens Find Careᆴ

On Dec. 21, 2020, LabCorp and Walgreens announced that the Pixel by Labcorpル At-Home COVID-19 Collection Kit is…

Read More Labcorp made Pixel At-Home COVID-19 Collection Kit available through Walgreens Find CareᆴContinue

Novan engaged Catalent to develop intranasal formulation of berdazimer sodium for COVID-19 program
COVID-19 | Life Science History

Novan engaged Catalent to develop intranasal formulation of berdazimer sodium for COVID-19 program

On Dec. 21, 2020, Novan announced it had entered into a Master Services Agreement (MSA) with Catalent, which…

Read More Novan engaged Catalent to develop intranasal formulation of berdazimer sodium for COVID-19 programContinue

Pfizer and BioNTech received CHMP positive opinion for their COVID-19 vaccine
COVID-19 | Life Science History

Pfizer and BioNTech received CHMP positive opinion for their COVID-19 vaccine

On Dec. 21, 2020, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…

Read More Pfizer and BioNTech received CHMP positive opinion for their COVID-19 vaccineContinue

Pfizer and BioNTech received authorization in the European Union for COVID-19 vaccine
COVID-19 | Life Science History

Pfizer and BioNTech received authorization in the European Union for COVID-19 vaccine

On Dec. 21, 2020, Pfizer and BioNTech announced that the European Commission (EC) had granted a conditional marketing…

Read More Pfizer and BioNTech received authorization in the European Union for COVID-19 vaccineContinue

OraSure updated Its Emergency Use Authorization application for lab-based oral SARS-CoV-2 antibody test
FDA | Life Science History

OraSure updated Its Emergency Use Authorization application for lab-based oral SARS-CoV-2 antibody test

On Dec. 21, 2020, OraSure Technologies disclosed that the FDA had requested additional information as part of its…

Read More OraSure updated Its Emergency Use Authorization application for lab-based oral SARS-CoV-2 antibody testContinue

CDC’s ACIP announced interim recommendation for use of Moderna COVID-19 Vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

CDC’s ACIP announced interim recommendation for use of Moderna COVID-19 Vaccine

On Dec. 19, 2020, after a transparent, evidence-based review of available data, the Advisory Committee on Immunization Practices…

Read More CDC’s ACIP announced interim recommendation for use of Moderna COVID-19 VaccineContinue

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics | Vaccine

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY

On Dec. 19, 2020, Pfizer and BioNTech announced they supplying an additional 100 million doses of COMIRNATY the…

Read More Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATYContinue

FDA approved prosthetic implant for above-the-knee amputations
FDA | Life Science History

FDA approved prosthetic implant for above-the-knee amputations

On Dec. 18, 2020, the FDA approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System,…

Read More FDA approved prosthetic implant for above-the-knee amputationsContinue

Page navigation

Previous PagePrevious 1 2 3 4 … 76 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search